Pulse Biosciences, Inc. (PLSE) is a novel bioelectric medicine company dedicated to improving the lives of patients battling a variety of conditions. The company is committed to progress clinical applications that address significant unmet medical needs and carries forward vast potential in immuno-oncology.
Founded in 2014 and based in Hayward, California, Pulse Biosciences, Inc is focused on developing and commercializing a platform using its proprietary "Nano-Pulse Stimulation" (NPS) technology. The NPS is a non-thermal, precise and localized technology that opens up new doors for medical advances. It’s designed to initiate cell death in the treatment of various types of solid tumors while sparing neighboring healthy tissue, hence becoming an innovative solution in the healthcare industry.
Pulse Biosciences, Inc places a significant emphasis on research and development. Their primary research focus revolves around using NPS technology to treat dermatological and aesthetic conditions as well as solid tumors. The company also examines the utility of NPS in additional applications, such as cardiac ablation and veterinary care.
The NPS technology platform by Pulse Biosciences has demonstrated encouraging results in several early trials in humans and animals. It has also been positively received by the scientific community, with many leading experts supportive of its potential.
One of the prominent applications of the NPS technology is CellFXTM, aimed at dermatology and aesthetics conditions. The CellFXTM system is used in procedures addressing sebaceous glands responsible for several dermatologic conditions such as sebaceous hyperplasia, acne, and skin rejuvenation.
Despite being relatively young, Pulse Biosciences, Inc has made a notable impact in the bioscience industry. The company’s mission of creating a distinct, clinically superior, operator-independent and patient-friendly tissue treatment methodology through its NPS technology is commendable. The diligence and commitment of Pulse Biosciences to continue its research and development efforts while maintaining its patient-focused mission symbolize a highly promising future for the company in the medical industry.